US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

InflaRx N.V.

2.10

+0.08003.96%

Post-market: 2.06-0.0382-1.82%18:31 EDT

Volume:419.89K

Turnover:873.38K

Market Cap:309.32M

PE:-3.67

High:2.12

Open:2.03

Low:2.03

Close:2.02

52wk High:2.95

52wk Low:0.7984

Shares:147.29M

Float Shares:106.00M

Volume Ratio:0.51

T/O Rate:0.40%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5715

EPS(LYR):-0.7963

ROE:-38.52%

ROA:-18.54%

PB:1.81

PE(LYR):-2.64

Loading ...

Overview Company News Filings

InflaRx to develop izicopan in AAV

Inflarx NV Files For Offerng Of Ordinary Shares, Size Not Disclosed - SEC Filing

InflaRx Gains on Plans for Kidney-Disorder Treatment, $150M Stock Offering

InflaRx prices 75,000,000-share offering at $2, raising $150 million

InflaRx targets izicopan development in ANCA-associated vasculitis, plans Phase 2 study

InflaRx Q1 2026 net loss narrows to €5.59 million; revenue flat at no revenue

InflaRx NV expected to post a loss of 14 cents a share - Earnings Preview

Analysts Are Bullish on These Healthcare Stocks: InflaRx (IFRX), Mirum Pharmaceuticals (MIRM)

InflaRx reports low reactive metabolite formation for izicopan in preclinical liver study

InflaRx NV expected to post a loss of 14 cents a share - Earnings Preview

InflaRx to report first-quarter results before market open, no conference call planned

InflaRx regains Nasdaq compliance after shares hold above $1 minimum bid price

InflaRx Price Target Maintained With a $14.00/Share by Guggenheim

April 2026 Penny Stocks To Watch For Potential Growth

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Pro Medicus Limited (OtherPMCUF) and InflaRx (IFRX)

InflaRx announces new izicopan in vitro findings

InflaRx announces annual shareholder meeting notice

Guggenheim Reaffirms Their Buy Rating on InflaRx (IFRX)

InflaRx presents vilobelimab data

InflaRx vilobelimab Phase 3 pyoderma gangrenosum trial ends early for futility

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/IFRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IFRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IFRX\",,,,,undefined,":{"symbol":"IFRX","market":"US","secType":"STK","nameCN":"InflaRx N.V.","latestPrice":2.1,"timestamp":1787342400000,"preClose":2.02,"halted":0,"volume":419890,"hourTrading":{"tag":"盘后","latestPrice":2.0618,"preClose":2.1,"latestTime":"18:31 EDT","volume":1647,"amount":3399.914,"timestamp":1787351508685,"change":-0.0382,"changeRate":-0.01819,"amplitude":0.01819},"delay":0,"changeRate":0.03960396039603964,"floatShares":106000000,"shares":147292900,"eps":-0.5715,"marketStatus":"Market Closed","change":0.08,"latestTime":"08-21 16:00:00 EDT","open":2.03,"high":2.12,"low":2.025,"amount":873375,"amplitude":0.04703,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.5715,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1510117200000,"exchange":"NASDAQ","adjPreClose":2.02,"preHourTrading":{"tag":"盘前","latestPrice":2.1222,"preClose":2.02,"latestTime":"08:01 EDT","volume":35,"amount":72.48599750000001,"timestamp":1787313708353,"change":0.1022,"changeRate":0.050594,"amplitude":0.050594},"postHourTrading":{"tag":"盘后","latestPrice":2.0618,"preClose":2.1,"latestTime":"18:31 EDT","volume":1647,"amount":3399.914,"timestamp":1787351508685,"change":-0.0382,"changeRate":-0.01819,"amplitude":0.01819},"volumeRatio":0.5076383064316056,"impliedVol":0.3695,"impliedVolPercentile":0.0438},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IFRX\",,,,,undefined,":{"symbol":"IFRX","floatShares":106000000,"roa":"-18.54%","roe":"-38.52%","lyrEps":-0.796269,"volumeRatio":0.5076383064316056,"shares":147292900,"dividePrice":0,"high":2.12,"amplitude":0.04703,"preClose":2.02,"low":2.025,"week52Low":0.7984,"pbRate":"1.81","psRate":"-26227.31","week52High":2.9489,"institutionHeld":0,"latestPrice":2.1,"eps":-0.5715,"divideRate":0,"volume":419890,"delay":0,"ttmEps":-0.5715,"open":2.03,"prevYearClose":1.01,"prevWeekClose":2.04,"prevMonthClose":1.7,"prevQuarterClose":2.24,"fiveDayClose":2.04,"twentyDayClose":1.74,"sixtyDayClose":2.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IFRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"IFRX","fiscalQuarterEnding":"2026/06","expectedEps":-0.08,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.11},{"date":"2026-05-07","symbol":"IFRX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/03","expectedEps":-0.17,"defaultRemindTime":1778140800000,"name":null,"time":"Pre-MKt","dateTimestamp":1778126400000,"actualEps":null},{"market":"US","date":"2026-03-19","symbol":"IFRX","fiscalQuarterEnding":"2025/12","expectedEps":-0.18,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"pre","actualEps":-0.17},{"market":"US","date":"2025-11-10","symbol":"IFRX","fiscalQuarterEnding":"2025/09","expectedEps":-0.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.16},{"market":"US","date":"2025-08-07","symbol":"IFRX","fiscalQuarterEnding":"2025/06","expectedEps":-0.24,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IFRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IFRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.5,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":8,"updateTime":1784606400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IFRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IFRX","date":"2026-08-21","current":-3.674541,"percent":0.082237,"low":-9.450046,"twenty":-3.79146,"median":-2.314372,"eighty":-1.540877,"high":-0.61166,"avg":-2.913639,"sd":1.947215,"marketCap":297683806},"quantilePoints":[{"date":"2021-08-27","current":-2.619465,"twenty":-25.692402,"median":-3.442339,"eighty":-2.121987,"marketCap":113116874},{"date":"2021-09-03","current":-2.629539,"twenty":-25.687287,"median":-3.426387,"eighty":-2.124476,"marketCap":114442462},{"date":"2021-09-10","current":-3.008915,"twenty":-25.681175,"median":-3.41157,"eighty":-2.126692,"marketCap":130349523},{"date":"2021-09-17","current":-2.80593,"twenty":-25.674949,"median":-3.397053,"eighty":-2.130135,"marketCap":120628541},{"date":"2021-09-24","current":-2.740723,"twenty":-25.665585,"median":-3.389807,"eighty":-2.134706,"marketCap":117535502},{"date":"2021-10-01","current":-2.664251,"twenty":-25.645992,"median":-3.376783,"eighty":-2.138732,"marketCap":113116874},{"date":"2021-10-08","current":-2.804412,"twenty":-25.638419,"median":-3.369345,"eighty":-2.139942,"marketCap":118861090},{"date":"2021-10-15","current":-2.568797,"twenty":-25.59942,"median":-3.355287,"eighty":-2.15103,"marketCap":109140109},{"date":"2021-10-22","current":-3.059811,"twenty":-25.561641,"median":-3.349052,"eighty":-2.154896,"marketCap":130349523},{"date":"2021-10-29","current":-4.423919,"twenty":-25.544343,"median":-3.348306,"eighty":-2.158087,"marketCap":187349822},{"date":"2021-11-05","current":-4.251839,"twenty":-25.536207,"median":-3.352563,"eighty":-2.163381,"marketCap":205466197},{"date":"2021-11-12","current":-5.149963,"twenty":-25.532701,"median":-3.369298,"eighty":-2.165514,"marketCap":246559436},{"date":"2021-11-19","current":-4.442446,"twenty":-25.494082,"median":-3.373909,"eighty":-2.169524,"marketCap":210326688},{"date":"2021-11-26","current":-4.743245,"twenty":-25.480025,"median":-3.383633,"eighty":-2.171417,"marketCap":224466297},{"date":"2021-12-03","current":-3.8471,"twenty":-25.476764,"median":-3.39115,"eighty":-2.172284,"marketCap":181605606},{"date":"2021-12-10","current":-3.950486,"twenty":-25.466679,"median":-3.407313,"eighty":-2.174154,"marketCap":186907960},{"date":"2021-12-17","current":-3.992006,"twenty":-25.456835,"median":-3.415357,"eighty":-2.176712,"marketCap":188233548},{"date":"2021-12-23","current":-4.34175,"twenty":-25.447224,"median":-3.439152,"eighty":-2.178157,"marketCap":205466197},{"date":"2021-12-31","current":-4.422329,"twenty":-25.434421,"median":-3.460422,"eighty":-2.181429,"marketCap":210326688},{"date":"2022-01-07","current":-3.615004,"twenty":-25.4299,"median":-3.469026,"eighty":-2.186377,"marketCap":171442762},{"date":"2022-01-14","current":-3.931443,"twenty":-25.423348,"median":-3.476311,"eighty":-2.188634,"marketCap":187791685},{"date":"2022-01-21","current":-3.27922,"twenty":-25.415798,"median":-3.480271,"eighty":-2.18983,"marketCap":155535702},{"date":"2022-01-28","current":-3.332032,"twenty":-25.405586,"median":-3.472316,"eighty":-2.191659,"marketCap":155535702},{"date":"2022-02-04","current":-3.277911,"twenty":-25.393185,"median":-3.463394,"eighty":-2.191987,"marketCap":156861290},{"date":"2022-02-11","current":-3.094239,"twenty":-25.349416,"median":-3.457906,"eighty":-2.192343,"marketCap":147582171},{"date":"2022-02-18","current":-2.908888,"twenty":-25.342061,"median":-3.438284,"eighty":-2.19268,"marketCap":137861190},{"date":"2022-02-25","current":-2.822869,"twenty":-25.330025,"median":-3.426102,"eighty":-2.193365,"marketCap":133000699},{"date":"2022-03-04","current":-2.042583,"twenty":-25.326961,"median":-3.408072,"eighty":-2.192509,"marketCap":93233048},{"date":"2022-03-11","current":-1.881926,"twenty":-25.319085,"median":-3.394102,"eighty":-2.189491,"marketCap":86163244},{"date":"2022-03-18","current":-2.091797,"twenty":-25.313085,"median":-3.389039,"eighty":-2.185207,"marketCap":96767951},{"date":"2022-03-25","current":-2.212947,"twenty":-25.309822,"median":-3.373909,"eighty":-2.178911,"marketCap":110951445},{"date":"2022-04-01","current":-1.667593,"twenty":-25.302123,"median":-3.369298,"eighty":-2.172439,"marketCap":83987149},{"date":"2022-04-08","current":-1.558658,"twenty":-25.300371,"median":-3.359638,"eighty":-2.164523,"marketCap":77356585},{"date":"2022-04-14","current":-1.613479,"twenty":-25.284057,"median":-3.352563,"eighty":-2.153506,"marketCap":79566773},{"date":"2022-04-22","current":-1.590703,"twenty":-25.274805,"median":-3.348306,"eighty":-2.139942,"marketCap":78240660},{"date":"2022-04-29","current":-1.553514,"twenty":-25.247442,"median":-3.341568,"eighty":-2.130135,"marketCap":74704359},{"date":"2022-05-06","current":-1.463033,"twenty":-25.232905,"median":-3.334919,"eighty":-2.118001,"marketCap":70726020},{"date":"2022-05-13","current":-1.158755,"twenty":-25.216013,"median":-3.326309,"eighty":-2.104355,"marketCap":64537493},{"date":"2022-05-20","current":-1.127654,"twenty":-25.153392,"median":-3.312666,"eighty":-2.090537,"marketCap":63653418},{"date":"2022-05-27","current":-1.133538,"twenty":-25.123387,"median":-3.307821,"eighty":-2.078473,"marketCap":64979531},{"date":"2022-06-03","current":-1.133052,"twenty":-25.102901,"median":-3.297547,"eighty":-2.071719,"marketCap":64979531},{"date":"2022-06-10","current":-1.099107,"twenty":-25.078955,"median":-3.285676,"eighty":-2.064881,"marketCap":61885268},{"date":"2022-06-17","current":-0.95534,"twenty":-25.058012,"median":-3.278566,"eighty":-2.059013,"marketCap":53486553},{"date":"2022-06-24","current":-0.61166,"twenty":-25.013779,"median":-3.274146,"eighty":-2.050697,"marketCap":34523138},{"date":"2022-07-01","current":-1.143714,"twenty":-24.953195,"median":-3.27019,"eighty":-2.039731,"marketCap":63653418},{"date":"2022-07-08","current":-1.249984,"twenty":-24.940061,"median":-3.266364,"eighty":-2.028029,"marketCap":68073795},{"date":"2022-07-15","current":-1.105244,"twenty":-24.912512,"median":-3.253607,"eighty":-2.016954,"marketCap":59675080},{"date":"2022-07-22","current":-1.090969,"twenty":-24.825431,"median":-3.232562,"eighty":-1.98678,"marketCap":59675080},{"date":"2022-07-29","current":-2.219243,"twenty":-24.705558,"median":-3.220144,"eighty":-1.924555,"marketCap":121118310},{"date":"2022-08-05","current":-3.310261,"twenty":-24.665355,"median":-3.208176,"eighty":-1.952888,"marketCap":128632950},{"date":"2022-08-12","current":-3.369138,"twenty":-24.623821,"median":-3.226312,"eighty":-1.980182,"marketCap":132169251},{"date":"2022-08-19","current":-2.876794,"twenty":-24.618574,"median":-3.208176,"eighty":-1.98678,"marketCap":110509407},{"date":"2022-08-26","current":-2.62393,"twenty":-24.606349,"median":-3.198154,"eighty":-2.009536,"marketCap":100342542},{"date":"2022-09-02","current":-2.648776,"twenty":-24.583084,"median":-3.186455,"eighty":-2.011689,"marketCap":101668654},{"date":"2022-09-09","current":-3.268037,"twenty":-24.575807,"median":-3.180921,"eighty":-2.016029,"marketCap":125538686},{"date":"2022-09-16","current":-3.112552,"twenty":-24.525387,"median":-3.168258,"eighty":-2.016818,"marketCap":119350160},{"date":"2022-09-23","current":-2.519124,"twenty":-24.51136,"median":-3.149642,"eighty":-2.017498,"marketCap":93711977},{"date":"2022-09-30","current":-3.110486,"twenty":-24.503768,"median":-3.141488,"eighty":-2.023142,"marketCap":116697934},{"date":"2022-10-07","current":-3.001762,"twenty":-24.499937,"median":-3.125003,"eighty":-2.026815,"marketCap":112277558},{"date":"2022-10-14","current":-2.833329,"twenty":-24.463679,"median":-3.11616,"eighty":-2.027695,"marketCap":105646993},{"date":"2022-10-21","current":-2.968518,"twenty":-24.434266,"median":-3.112552,"eighty":-2.029366,"marketCap":111393482},{"date":"2022-10-28","current":-3.044242,"twenty":-24.387783,"median":-3.104843,"eighty":-2.031686,"marketCap":115813859},{"date":"2022-11-04","current":-2.925419,"twenty":-24.386265,"median":-3.100143,"eighty":-2.034524,"marketCap":110951445},{"date":"2022-11-11","current":-3.360927,"twenty":-24.374133,"median":-3.104843,"eighty":-2.038158,"marketCap":118466084},{"date":"2022-11-18","current":-3.187327,"twenty":-24.357612,"median":-3.106216,"eighty":-2.04209,"marketCap":112719595},{"date":"2022-11-25","current":-3.114145,"twenty":-24.321314,"median":-3.103471,"eighty":-2.042484,"marketCap":110509407},{"date":"2022-12-02","current":-3.199416,"twenty":-24.305952,"median":-3.109484,"eighty":-2.045113,"marketCap":114487746},{"date":"2022-12-09","current":-2.839171,"twenty":-24.296418,"median":-3.103471,"eighty":-2.048262,"marketCap":102110692},{"date":"2022-12-16","current":-2.626368,"twenty":-24.268656,"median":-3.098225,"eighty":-2.052502,"marketCap":95038090},{"date":"2022-12-23","current":-3.963354,"twenty":-24.249087,"median":-3.100143,"eighty":-2.05414,"marketCap":143662229},{"date":"2022-12-30","current":-3.757141,"twenty":-24.236402,"median":-3.103471,"eighty":-2.05494,"marketCap":137031665},{"date":"2023-01-06","current":-3.429325,"twenty":-24.187068,"median":-3.103471,"eighty":-2.05494,"marketCap":124212574},{"date":"2023-01-13","current":-3.148676,"twenty":-24.119807,"median":-3.103471,"eighty":-2.05494,"marketCap":116255896},{"date":"2023-01-20","current":-2.87463,"twenty":-24.060794,"median":-3.095243,"eighty":-2.05494,"marketCap":106310050},{"date":"2023-01-27","current":-2.684699,"twenty":-23.889509,"median":-3.081171,"eighty":-2.05494,"marketCap":99458466},{"date":"2023-02-03","current":-2.625894,"twenty":-23.753924,"median":-3.075373,"eighty":-2.05494,"marketCap":97248278},{"date":"2023-02-10","current":-2.437904,"twenty":-23.637734,"median":-3.064648,"eighty":-2.05494,"marketCap":88849563},{"date":"2023-02-17","current":-2.733077,"twenty":-23.443338,"median":-3.059811,"eighty":-2.05494,"marketCap":99458466},{"date":"2023-02-24","current":-2.504414,"twenty":-23.240436,"median":-3.05296,"eighty":-2.05494,"marketCap":90175676},{"date":"2023-03-03","current":-2.223958,"twenty":-23.091745,"median":-3.042742,"eighty":-2.05494,"marketCap":80450848},{"date":"2023-03-10","current":-2.185996,"twenty":-22.971614,"median":-3.031527,"eighty":-2.05494,"marketCap":79566773},{"date":"2023-03-17","current":-2.017049,"twenty":-22.749108,"median":-3.015708,"eighty":-2.053956,"marketCap":73378246},{"date":"2023-03-24","current":-2.536982,"twenty":-22.567429,"median":-3.002572,"eighty":-2.051599,"marketCap":80466773},{"date":"2023-03-31","current":-2.707242,"twenty":-22.293774,"median":-2.985327,"eighty":-2.052502,"marketCap":86725300},{"date":"2023-04-06","current":-8.468992,"twenty":-22.221188,"median":-2.980368,"eighty":-2.050697,"marketCap":272692954},{"date":"2023-04-19","current":-7.539816,"twenty":-21.900043,"median":-2.966913,"eighty":-2.045113,"marketCap":243679193},{"date":"2023-04-28","current":-8.425592,"twenty":-21.574969,"median":-2.964258,"eighty":-2.043848,"marketCap":273807214},{"date":"2023-05-05","current":-8.149129,"twenty":-21.326308,"median":-2.964258,"eighty":-2.043848,"marketCap":264385891},{"date":"2023-05-12","current":-8.961759,"twenty":-21.165358,"median":-2.964258,"eighty":-2.043848,"marketCap":288528032},{"date":"2023-05-19","current":-8.105007,"twenty":-20.576815,"median":-2.964258,"eighty":-2.043848,"marketCap":257319898},{"date":"2023-05-26","current":-7.634536,"twenty":-18.895891,"median":-2.964258,"eighty":-2.043848,"marketCap":241421415},{"date":"2023-06-02","current":-8.897592,"twenty":-17.2313,"median":-2.964258,"eighty":-2.043848,"marketCap":253786902},{"date":"2023-06-09","current":-8.238655,"twenty":-8.997075,"median":-2.964258,"eighty":-2.043848,"marketCap":235827504},{"date":"2023-06-16","current":-9.028798,"twenty":-8.93681,"median":-2.964258,"eighty":-2.043848,"marketCap":262030560},{"date":"2023-06-23","current":-9.140768,"twenty":-8.899027,"median":-2.963209,"eighty":-2.043216,"marketCap":266152389},{"date":"2023-06-30","current":-9.039015,"twenty":-8.897592,"median":-2.962755,"eighty":-2.042583,"marketCap":261441727},{"date":"2023-07-07","current":-7.957828,"twenty":-8.77461,"median":-2.962755,"eighty":-2.042583,"marketCap":229644760},{"date":"2023-07-14","current":-8.574185,"twenty":-8.60592,"median":-2.962755,"eighty":-2.042583,"marketCap":254964567},{"date":"2023-07-21","current":-8.113503,"twenty":-8.47995,"median":-2.962755,"eighty":-2.042583,"marketCap":240243749},{"date":"2023-07-28","current":-8.208184,"twenty":-8.435717,"median":-2.962755,"eighty":-2.042583,"marketCap":239654917},{"date":"2023-08-04","current":-8.299584,"twenty":-8.360313,"median":-2.962755,"eighty":-2.042583,"marketCap":241421415},{"date":"2023-08-11","current":-6.068497,"twenty":-8.239877,"median":-2.962755,"eighty":-2.042583,"marketCap":235533088},{"date":"2023-08-18","current":-5.82274,"twenty":-8.188318,"median":-2.962755,"eighty":-2.042583,"marketCap":223167600},{"date":"2023-08-25","current":-5.909797,"twenty":-8.105007,"median":-2.962755,"eighty":-2.042583,"marketCap":225522931},{"date":"2023-09-01","current":-6.086379,"twenty":-7.942756,"median":-2.962301,"eighty":-2.042484,"marketCap":232588924},{"date":"2023-09-08","current":-6.122042,"twenty":-7.841561,"median":-2.962301,"eighty":-2.042484,"marketCap":230822426},{"date":"2023-09-15","current":-6.047691,"twenty":-7.657546,"median":-2.962301,"eighty":-2.042484,"marketCap":227289429},{"date":"2023-09-22","current":-4.87418,"twenty":-7.215475,"median":-2.960275,"eighty":-2.042386,"marketCap":183126975},{"date":"2023-09-29","current":-4.665817,"twenty":-6.271729,"median":-2.960275,"eighty":-2.042386,"marketCap":173705652},{"date":"2023-10-06","current":-4.095273,"twenty":-6.07565,"median":-2.960275,"eighty":-2.042386,"marketCap":151918841},{"date":"2023-10-13","current":-3.864893,"twenty":-5.857563,"median":-2.960275,"eighty":-2.042386,"marketCap":143675183},{"date":"2023-10-20","current":-3.286668,"twenty":-5.646626,"median":-2.960275,"eighty":-2.042386,"marketCap":122477205},{"date":"2023-10-27","current":-2.697868,"twenty":-5.537504,"median":-2.950514,"eighty":-2.04209,"marketCap":100101562},{"date":"2023-11-03","current":-2.233806,"twenty":-5.197421,"median":-2.928023,"eighty":-2.04209,"marketCap":82436580},{"date":"2023-11-10","current":-2.087155,"twenty":-4.907963,"median":-2.91242,"eighty":-2.04209,"marketCap":77725919},{"date":"2023-11-17","current":-2.261025,"twenty":-4.743245,"median":-2.905286,"eighty":-2.034524,"marketCap":85380744},{"date":"2023-11-24","current":-2.252183,"twenty":-4.665817,"median":-2.892865,"eighty":-2.034524,"marketCap":85380744},{"date":"2023-12-01","current":-2.096632,"twenty":-4.532206,"median":-2.879719,"eighty":-2.031686,"marketCap":79492417},{"date":"2023-12-08","current":-2.197999,"twenty":-4.48737,"median":-2.868186,"eighty":-2.032254,"marketCap":82436580},{"date":"2023-12-15","current":-2.110521,"twenty":-4.438457,"median":-2.833849,"eighty":-2.032254,"marketCap":80670082},{"date":"2023-12-22","current":-2.280481,"twenty":-4.370666,"median":-2.82501,"eighty":-2.031763,"marketCap":87147242},{"date":"2023-12-29","current":-2.538435,"twenty":-4.33424,"median":-2.816208,"eighty":-2.031686,"marketCap":97746231},{"date":"2024-01-05","current":-2.828463,"twenty":-4.286188,"median":-2.805171,"eighty":-2.031222,"marketCap":107756387},{"date":"2024-01-12","current":-2.707482,"twenty":-4.256229,"median":-2.79763,"eighty":-2.031222,"marketCap":103045726},{"date":"2024-01-19","current":-2.494382,"twenty":-4.232858,"median":-2.773571,"eighty":-2.030758,"marketCap":94213235},{"date":"2024-01-26","current":-2.344327,"twenty":-4.195043,"median":-2.765202,"eighty":-2.031222,"marketCap":88324908},{"date":"2024-02-02","current":-2.654313,"twenty":-4.16251,"median":-2.743527,"eighty":-2.031222,"marketCap":100101562},{"date":"2024-02-09","current":-2.486219,"twenty":-4.136824,"median":-2.732222,"eighty":-2.031222,"marketCap":93035569},{"date":"2024-02-16","current":-2.42458,"twenty":-4.095212,"median":-2.710198,"eighty":-2.031222,"marketCap":90680238},{"date":"2024-02-23","current":-2.301923,"twenty":-4.077605,"median":-2.703082,"eighty":-2.031222,"marketCap":86558409},{"date":"2024-03-01","current":-2.789171,"twenty":-4.072563,"median":-2.697868,"eighty":-2.031686,"marketCap":104812224},{"date":"2024-03-08","current":-2.572738,"twenty":-4.024419,"median":-2.697241,"eighty":-2.031686,"marketCap":97746231},{"date":"2024-03-15","current":-2.363742,"twenty":-4.006418,"median":-2.688162,"eighty":-2.031686,"marketCap":89502573},{"date":"2024-03-22","current":-1.957166,"twenty":-3.989235,"median":-2.683334,"eighty":-2.029366,"marketCap":90680238},{"date":"2024-03-28","current":-1.96758,"twenty":-3.977045,"median":-2.670879,"eighty":-2.026815,"marketCap":90680238},{"date":"2024-04-05","current":-1.981938,"twenty":-3.964341,"median":-2.658011,"eighty":-2.01666,"marketCap":91857904},{"date":"2024-04-12","current":-1.984369,"twenty":-3.932271,"median":-2.654637,"eighty":-1.983883,"marketCap":90680238},{"date":"2024-04-19","current":-1.630704,"twenty":-3.866737,"median":-2.638291,"eighty":-1.97026,"marketCap":74192922},{"date":"2024-04-26","current":-1.790703,"twenty":-3.836036,"median":-2.634291,"eighty":-1.962479,"marketCap":81847748},{"date":"2024-05-03","current":-1.780105,"twenty":-3.78565,"median":-2.628724,"eighty":-1.946126,"marketCap":81258915},{"date":"2024-05-10","current":-1.590155,"twenty":-3.773538,"median":-2.625321,"eighty":-1.897734,"marketCap":70659926},{"date":"2024-05-17","current":-1.904668,"twenty":-3.753351,"median":-2.61868,"eighty":-1.886655,"marketCap":85380744},{"date":"2024-05-24","current":-1.952316,"twenty":-3.735549,"median":-2.606627,"eighty":-1.886655,"marketCap":87147242},{"date":"2024-05-31","current":-1.882889,"twenty":-3.684127,"median":-2.593785,"eighty":-1.882889,"marketCap":84203078},{"date":"2024-06-07","current":-2.112539,"twenty":-3.653656,"median":-2.588348,"eighty":-1.881926,"marketCap":94802067},{"date":"2024-06-14","current":-2.016149,"twenty":-3.654543,"median":-2.588093,"eighty":-1.881261,"marketCap":89502573},{"date":"2024-06-21","current":-1.971968,"twenty":-3.65543,"median":-2.585869,"eighty":-1.880596,"marketCap":87147242},{"date":"2024-06-28","current":-2.227273,"twenty":-3.658092,"median":-2.588093,"eighty":-1.878601,"marketCap":98335064},{"date":"2024-07-05","current":-2.152746,"twenty":-3.658092,"median":-2.584246,"eighty":-1.878601,"marketCap":95979733},{"date":"2024-07-12","current":-2.154011,"twenty":-3.658092,"median":-2.579459,"eighty":-1.878601,"marketCap":96568566},{"date":"2024-07-15","current":-2.132266,"twenty":-3.658092,"median":-2.579459,"eighty":-1.878601,"marketCap":95979733},{"date":"2024-08-02","current":-2.012243,"twenty":-3.698487,"median":-2.587838,"eighty":-1.867194,"marketCap":89502573},{"date":"2024-08-09","current":-1.542577,"twenty":-3.698487,"median":-2.587838,"eighty":-1.851127,"marketCap":78903584},{"date":"2024-08-16","current":-1.543577,"twenty":-3.698487,"median":-2.587838,"eighty":-1.84579,"marketCap":79492417},{"date":"2024-08-23","current":-1.707365,"twenty":-3.698487,"median":-2.587838,"eighty":-1.84579,"marketCap":88913740},{"date":"2024-08-30","current":-1.882183,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":97746231},{"date":"2024-09-06","current":-1.77856,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":92446737},{"date":"2024-09-13","current":-1.638886,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":84791911},{"date":"2024-09-20","current":-1.7139,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":89502573},{"date":"2024-09-27","current":-1.730455,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":90680238},{"date":"2024-10-04","current":-1.77879,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":91857904},{"date":"2024-10-11","current":-1.678334,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":85969577},{"date":"2024-10-18","current":-1.797756,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":91269071},{"date":"2024-10-25","current":-1.86037,"twenty":-3.698487,"median":-2.587838,"eighty":-1.849356,"marketCap":94213235},{"date":"2024-10-31","current":-1.816024,"twenty":-3.698487,"median":-2.587838,"eighty":-1.849356,"marketCap":92446737},{"date":"2024-11-08","current":-1.75819,"twenty":-3.703273,"median":-2.588093,"eighty":-1.853721,"marketCap":88913740},{"date":"2024-11-15","current":-1.986236,"twenty":-3.703273,"median":-2.588093,"eighty":-1.85898,"marketCap":119533042},{"date":"2024-11-22","current":-2.032862,"twenty":-3.703273,"median":-2.588093,"eighty":-1.873049,"marketCap":121299540},{"date":"2024-11-29","current":-2.413842,"twenty":-3.703273,"median":-2.588093,"eighty":-1.881058,"marketCap":144852849},{"date":"2024-12-06","current":-2.409258,"twenty":-3.703273,"median":-2.588093,"eighty":-1.888141,"marketCap":144852849},{"date":"2024-12-13","current":-2.279807,"twenty":-3.703273,"median":-2.588093,"eighty":-1.905561,"marketCap":136020358},{"date":"2024-12-20","current":-2.123768,"twenty":-3.703273,"median":-2.588093,"eighty":-1.919808,"marketCap":125421369},{"date":"2024-12-27","current":-2.594259,"twenty":-3.703273,"median":-2.590889,"eighty":-1.928389,"marketCap":153685339},{"date":"2025-01-03","current":-2.523482,"twenty":-3.703273,"median":-2.593524,"eighty":-1.945481,"marketCap":147208180},{"date":"2025-01-10","current":-2.342961,"twenty":-3.70806,"median":-2.593617,"eighty":-1.957166,"marketCap":137198023},{"date":"2025-01-17","current":-2.564185,"twenty":-3.70806,"median":-2.593617,"eighty":-1.96758,"marketCap":150152343},{"date":"2025-01-24","current":-2.356442,"twenty":-3.70806,"median":-2.593617,"eighty":-1.978631,"marketCap":139553354},{"date":"2025-01-31","current":-2.353498,"twenty":-3.70806,"median":-2.593617,"eighty":-1.994331,"marketCap":139553354},{"date":"2025-02-07","current":-2.534146,"twenty":-3.70806,"median":-2.593617,"eighty":-2.012243,"marketCap":149563510},{"date":"2025-02-14","current":-2.676169,"twenty":-3.70806,"median":-2.594259,"eighty":-2.017073,"marketCap":158984834},{"date":"2025-02-21","current":-1.830033,"twenty":-3.70806,"median":-2.594259,"eighty":-2.016149,"marketCap":108934053},{"date":"2025-02-28","current":-1.342976,"twenty":-3.70806,"median":-2.594259,"eighty":-2.007413,"marketCap":79492417},{"date":"2025-03-07","current":-1.156608,"twenty":-3.708133,"median":-2.594022,"eighty":-1.983883,"marketCap":71248759},{"date":"2025-03-14","current":-1.095804,"twenty":-3.708133,"median":-2.594022,"eighty":-1.983883,"marketCap":67715762},{"date":"2025-03-21","current":-1.484361,"twenty":-3.708133,"median":-2.594022,"eighty":-1.983883,"marketCap":74192922},{"date":"2025-03-28","current":-1.699421,"twenty":-3.708133,"median":-2.594022,"eighty":-1.983883,"marketCap":84502137},{"date":"2025-04-04","current":-1.392072,"twenty":-3.708133,"median":-2.593524,"eighty":-1.978954,"marketCap":70981795},{"date":"2025-04-11","current":-1.180921,"twenty":-3.70806,"median":-2.588348,"eighty":-1.96758,"marketCap":60841539},{"date":"2025-04-17","current":-1.355089,"twenty":-3.70806,"median":-2.587838,"eighty":-1.958598,"marketCap":70981795},{"date":"2025-04-25","current":-1.706059,"twenty":-3.708133,"median":-2.586854,"eighty":-1.944521,"marketCap":89234257},{"date":"2025-05-02","current":-2.407629,"twenty":-3.708133,"median":-2.583083,"eighty":-1.926392,"marketCap":125063163},{"date":"2025-05-09","current":-2.118244,"twenty":-3.708133,"median":-2.577703,"eighty":-1.926392,"marketCap":106810701},{"date":"2025-05-16","current":-2.410655,"twenty":-3.708133,"median":-2.573155,"eighty":-1.926392,"marketCap":120589891},{"date":"2025-05-23","current":-2.443597,"twenty":-3.679696,"median":-2.568267,"eighty":-1.926392,"marketCap":123299776},{"date":"2025-05-30","current":-1.13339,"twenty":-3.647428,"median":-2.563851,"eighty":-1.913307,"marketCap":57591835},{"date":"2025-06-06","current":-1.123178,"twenty":-3.626423,"median":-2.55507,"eighty":-1.889126,"marketCap":57517313},{"date":"2025-06-13","current":-1.047083,"twenty":-3.626423,"median":-2.541295,"eighty":-1.880393,"marketCap":54197704},{"date":"2025-06-20","current":-1.054136,"twenty":-3.62668,"median":-2.538033,"eighty":-1.875322,"marketCap":54062209},{"date":"2025-06-27","current":-1.078148,"twenty":-3.62668,"median":-2.538033,"eighty":-1.847382,"marketCap":56406260},{"date":"2025-07-03","current":-1.03345,"twenty":-3.62668,"median":-2.538033,"eighty":-1.835407,"marketCap":54360297},{"date":"2025-07-11","current":-1.160295,"twenty":-3.62668,"median":-2.538033,"eighty":-1.822354,"marketCap":60647230},{"date":"2025-07-18","current":-1.134508,"twenty":-3.62668,"median":-2.538033,"eighty":-1.809629,"marketCap":58797734},{"date":"2025-07-25","current":-1.094112,"twenty":-3.62668,"median":-2.538033,"eighty":-1.799033,"marketCap":57591835},{"date":"2025-08-01","current":-1.198497,"twenty":-3.62668,"median":-2.538033,"eighty":-1.790625,"marketCap":61311152},{"date":"2025-08-08","current":-1.048287,"twenty":-3.62668,"median":-2.538033,"eighty":-1.779579,"marketCap":55220685},{"date":"2025-08-15","current":-1.062121,"twenty":-3.62668,"median":-2.538033,"eighty":-1.773402,"marketCap":56047200},{"date":"2025-08-22","current":-1.15665,"twenty":-3.62668,"median":-2.538033,"eighty":-1.764837,"marketCap":60836922},{"date":"2025-08-29","current":-1.500694,"twenty":-3.62668,"median":-2.538033,"eighty":-1.751777,"marketCap":79264142},{"date":"2025-09-05","current":-2.017509,"twenty":-3.626938,"median":-2.538234,"eighty":-1.751639,"marketCap":106362994},{"date":"2025-09-12","current":-1.872294,"twenty":-3.62668,"median":-2.538033,"eighty":-1.751777,"marketCap":99588281},{"date":"2025-09-19","current":-1.738574,"twenty":-3.62668,"median":-2.538033,"eighty":-1.741257,"marketCap":92813568},{"date":"2025-09-26","current":-1.652681,"twenty":-3.62668,"median":-2.538033,"eighty":-1.733002,"marketCap":87393797},{"date":"2025-10-03","current":-1.764269,"twenty":-3.62668,"median":-2.538033,"eighty":-1.729865,"marketCap":93491039},{"date":"2025-10-10","current":-1.888603,"twenty":-3.62668,"median":-2.538033,"eighty":-1.729865,"marketCap":98910809},{"date":"2025-10-17","current":-1.589181,"twenty":-3.62668,"median":-2.538033,"eighty":-1.715896,"marketCap":84006441},{"date":"2025-10-24","current":-1.572126,"twenty":-3.62668,"median":-2.538033,"eighty":-1.710768,"marketCap":82651498},{"date":"2025-10-31","current":-1.707503,"twenty":-3.62668,"median":-2.536982,"eighty":-1.708857,"marketCap":89426211},{"date":"2025-11-07","current":-1.555866,"twenty":-3.62668,"median":-2.534146,"eighty":-1.707448,"marketCap":81296556},{"date":"2025-11-14","current":-1.842931,"twenty":-3.62668,"median":-2.532153,"eighty":-1.706843,"marketCap":86038855},{"date":"2025-11-21","current":-1.683561,"twenty":-3.62668,"median":-2.529404,"eighty":-1.704879,"marketCap":77909199},{"date":"2025-11-28","current":-1.835231,"twenty":-3.62668,"median":-2.52731,"eighty":-1.704879,"marketCap":85361383},{"date":"2025-12-05","current":-1.593453,"twenty":-3.62668,"median":-2.52731,"eighty":-1.699337,"marketCap":74521843},{"date":"2025-12-12","current":-1.46602,"twenty":-3.62668,"median":-2.519124,"eighty":-1.679502,"marketCap":69102072},{"date":"2025-12-19","current":-1.524944,"twenty":-3.62668,"median":-2.509756,"eighty":-1.667406,"marketCap":71811957},{"date":"2025-12-26","current":-1.634642,"twenty":-3.62668,"median":-2.502779,"eighty":-1.658358,"marketCap":77231728},{"date":"2026-01-02","current":-1.452671,"twenty":-3.62668,"median":-2.494862,"eighty":-1.654063,"marketCap":68424601},{"date":"2026-01-09","current":-1.580071,"twenty":-3.62668,"median":-2.49125,"eighty":-1.646849,"marketCap":73844371},{"date":"2026-01-16","current":-1.455182,"twenty":-3.615874,"median":-2.479169,"eighty":-1.636099,"marketCap":67747130},{"date":"2026-01-23","current":-1.480915,"twenty":-3.615874,"median":-2.472232,"eighty":-1.62913,"marketCap":69779543},{"date":"2026-01-30","current":-1.306377,"twenty":-3.615874,"median":-2.463946,"eighty":-1.611667,"marketCap":62510276},{"date":"2026-02-06","current":-1.182562,"twenty":-3.615874,"median":-2.454336,"eighty":-1.599547,"marketCap":55918481},{"date":"2026-02-13","current":-1.183431,"twenty":-3.615874,"median":-2.437007,"eighty":-1.592464,"marketCap":56318189},{"date":"2026-02-20","current":-1.253127,"twenty":-3.593673,"median":-2.426574,"eighty":-1.590155,"marketCap":59129695},{"date":"2026-02-27","current":-1.333814,"twenty":-3.582235,"median":-2.418167,"eighty":-1.586876,"marketCap":63092902},{"date":"2026-03-06","current":-1.344198,"twenty":-3.559755,"median":-2.407629,"eighty":-1.575542,"marketCap":62334134},{"date":"2026-03-13","current":-1.437495,"twenty":-3.516775,"median":-2.396656,"eighty":-1.571306,"marketCap":66453159},{"date":"2026-03-20","current":-1.170912,"twenty":-3.481466,"median":-2.375348,"eighty":-1.561292,"marketCap":61622789},{"date":"2026-03-27","current":-1.277353,"twenty":-3.462757,"median":-2.363742,"eighty":-1.557873,"marketCap":67232358},{"date":"2026-04-02","current":-1.239124,"twenty":-3.455746,"median":-2.356018,"eighty":-1.553395,"marketCap":65280451},{"date":"2026-04-10","current":-1.394796,"twenty":-3.431158,"median":-2.353016,"eighty":-1.543577,"marketCap":74461644},{"date":"2026-04-17","current":-1.614359,"twenty":-3.363623,"median":-2.3395,"eighty":-1.541148,"marketCap":86751430},{"date":"2026-04-24","current":-2.109788,"twenty":-3.344491,"median":-2.322895,"eighty":-1.541148,"marketCap":112776860},{"date":"2026-05-01","current":-2.795263,"twenty":-3.321769,"median":-2.31439,"eighty":-1.541148,"marketCap":149646218},{"date":"2026-05-08","current":-3.792913,"twenty":-3.30237,"median":-2.31439,"eighty":-1.541148,"marketCap":191576076},{"date":"2026-05-15","current":-6.998494,"twenty":-3.321769,"median":-2.31439,"eighty":-1.541148,"marketCap":350557004},{"date":"2026-05-22","current":-7.317402,"twenty":-3.339281,"median":-2.31439,"eighty":-1.541148,"marketCap":363813361},{"date":"2026-05-29","current":-7.00993,"twenty":-3.34626,"median":-2.314381,"eighty":-1.541012,"marketCap":350557004},{"date":"2026-06-05","current":-5.905114,"twenty":-3.362489,"median":-2.31439,"eighty":-1.541148,"marketCap":294585718},{"date":"2026-06-12","current":-5.004121,"twenty":-3.362489,"median":-2.31439,"eighty":-1.541148,"marketCap":247452003},{"date":"2026-06-18","current":-5.442995,"twenty":-3.362489,"median":-2.31439,"eighty":-1.541148,"marketCap":268073003},{"date":"2026-06-26","current":-5.60795,"twenty":-3.359109,"median":-2.314381,"eighty":-1.541012,"marketCap":273964717},{"date":"2026-07-02","current":-6.988224,"twenty":-3.359109,"median":-2.314381,"eighty":-1.541012,"marketCap":343192361},{"date":"2026-07-10","current":-6.185501,"twenty":-3.36855,"median":-2.314381,"eighty":-1.541012,"marketCap":303423289},{"date":"2026-07-17","current":-5.730511,"twenty":-3.441547,"median":-2.314381,"eighty":-1.541012,"marketCap":281329360},{"date":"2026-07-24","current":-5.222528,"twenty":-3.469688,"median":-2.314381,"eighty":-1.541012,"marketCap":254816646},{"date":"2026-07-31","current":-5.127989,"twenty":-3.54332,"median":-2.314372,"eighty":-1.540877,"marketCap":253343717},{"date":"2026-08-07","current":-5.616396,"twenty":-3.652622,"median":-2.314372,"eighty":-1.540877,"marketCap":253343717},{"date":"2026-08-14","current":-6.559138,"twenty":-3.743947,"median":-2.314372,"eighty":-1.540877,"marketCap":296210124},{"date":"2026-08-21","current":-6.51116,"twenty":-3.79146,"median":-2.314372,"eighty":-1.540877,"marketCap":297683806}],"updateTime":1787506996236},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IFRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633193016","title":"InflaRx to develop izicopan in AAV","url":"https://stock-news.laohu8.com/highlight/detail?id=2633193016","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633193016?lang=en_us&edition=fundamental","pubTime":"2026-05-07 11:51","pubTimestamp":1778125889,"startTime":"0","endTime":"0","summary":"InflaRx (IFRX) announced that it intends to develop izicopan, an oral C5a receptor inhibitor, in AAV, a life-threatening kidney disorder. InflaRx i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inflarx-to-develop-izicopan-in-aav-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inflarx-to-develop-izicopan-in-aav-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IFRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633168994","title":"Inflarx NV Files For Offerng Of Ordinary Shares, Size Not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633168994","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633168994?lang=en_us&edition=fundamental","pubTime":"2026-05-07 05:25","pubTimestamp":1778102705,"startTime":"0","endTime":"0","summary":"InflaRx NV ::*INFLARX NV: FILES FOR OFFERNG OF ORDINARY SHARES, SIZE NOT DISCLOSED - SEC FILING  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-MAY-202621:11:41 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nRSD4K7186:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IFRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633276158","title":"InflaRx Gains on Plans for Kidney-Disorder Treatment, $150M Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2633276158","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633276158?lang=en_us&edition=fundamental","pubTime":"2026-05-07 01:29","pubTimestamp":1778088540,"startTime":"0","endTime":"0","summary":"Shares of InflaRx rose after the biopharmaceutical company said it is advancing development of izicopan, a kidney-disorder treatment, and said it would raise $150 million through a stock offering.Shares climbed 29%, to $2.54, Wednesday afternoon. The stock has gained about one-and-a-half times its value this year.The company said Wednesday that it was conducting Phase 2 planning for izicopan to treat ANCA-associated vasculitis, a life-threatening form of kidney disease.The German company is also working to establish proof of concept for the drug across other kidney diseases, including atypical hemolytic uremic syndrome, IgA nephropathy and C3 glomerulopathy. It intends to conduct open-label studies that are expected to begin generating clinical data next year.\"We have elected to pursue development in ANCA-associated vasculitis following our thorough evaluation of the high unmet need in this life-threatening disease and izicopan's promise as a significantly differentiated inhibitor of C","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"InflaRx Gains on Plans for Kidney-Disorder Treatment, $150M Stock Offering","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IFRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633133468","title":"InflaRx prices 75,000,000-share offering at $2, raising $150 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633133468","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633133468?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:32","pubTimestamp":1778070758,"startTime":"0","endTime":"0","summary":"InflaRx priced underwritten follow-on offering of 75,000,000 ordinary shares at USD 2 per share, targeting gross proceeds of USD 150 million.Closing expected May 7, 2026, subject to customary conditions.Net proceeds earmarked for pipeline advancement, working capital, general corporate purposes.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDLbfCPWQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4585","LU2210150020.SGD","BK4588","LU2210149790.SGD","BK4112","NDAQ","BK4139","SG9999014005.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","LU2095319765.USD","SG9999014013.SGD","IFRX","SG9999014021.USD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633336171","title":"InflaRx targets izicopan development in ANCA-associated vasculitis, plans Phase 2 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2633336171","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633336171?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:25","pubTimestamp":1778070321,"startTime":"0","endTime":"0","summary":"InflaRx pivoted izicopan development toward ANCA-associated vasculitis, planning a Phase 2 program while weighing options for a faster regulatory path amid shifting expectations around approved comparator avacopan.Strategy adds open-label renal studies to deliver rapid proof-of-concept data from 2027 in select complement-mediated kidney diseases, including atypical hemolytic uremic syndrome, IgA nephropathy, C3 glomerulopathy.China pharmacokinetic bridging study targeted for 2026 to support broader development plans.Funding runway projected through 2029 to cover Phase 2 AAV readout, proof-of-concept readouts in renal indications, ongoing operations.Capital Markets Day planned for summer 2026 to outline positioning for izicopan across AAV and renal disorders; hidradenitis suppurativa development kept as partner-led option with market potential cited above $1.5 billion per year.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL350dwM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IFRX","SG9999014021.USD","BK4139","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4588","SG9999014039.USD","BK4112","IE00BKPKM429.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","LU2095319765.USD","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00B64PRP62.GBP","NDAQ","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633382021","title":"InflaRx Q1 2026 net loss narrows to €5.59 million; revenue flat at no revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2633382021","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633382021?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:11","pubTimestamp":1778069475,"startTime":"0","endTime":"0","summary":"Inflarx posted a net loss of 5.59 million, or 0.08 a share, for the three months ended March 31, 2026.Operating loss narrowed to 7.21 million from 13.01 million a year earlier.No revenue was recorded, reflecting discontinuation of GOHIBIC  sales activities in the United States in December 2025.Research and development expense fell to 4.17 million from 7.02 million, while general and administrative expense dropped to 3.18 million from 5.06 million.Cash and cash equivalents slipped to 14.99 million at March 31, 2026 from 16.02 million at end-2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inflarx NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval syste","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDLc8sZSk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IFRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633629943","title":"InflaRx NV  expected to post a loss of 14 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633629943","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633629943?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:50","pubTimestamp":1777985420,"startTime":"0","endTime":"0","summary":"InflaRx NV  expected to post a loss of14cents a share - Earnings Preview InflaRx NV IFRX.OQ, IFRX.O is expected to  show a rise in quarterly revenue when it reports  results on May 7 for the period en","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL8N41I1MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IFRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632951252","title":"Analysts Are Bullish on These Healthcare Stocks: InflaRx (IFRX), Mirum Pharmaceuticals (MIRM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632951252","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632951252?lang=en_us&edition=fundamental","pubTime":"2026-05-04 22:50","pubTimestamp":1777906209,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on InflaRx (IFRX) and Mirum Pharmaceuticals (MIRM) with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-inflarx-ifrx-mirum-pharmaceuticals-mirm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-inflarx-ifrx-mirum-pharmaceuticals-mirm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4581","BLSG","LU0128526141.USD","BK4112","BK4585","LABU","BK4137","BK4588","MIRM","IFRX","BLSX","XBI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632121930","title":"InflaRx reports low reactive metabolite formation for izicopan in preclinical liver study","url":"https://stock-news.laohu8.com/highlight/detail?id=2632121930","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632121930?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:32","pubTimestamp":1777894328,"startTime":"0","endTime":"0","summary":"InflaRx disclosed new pre-clinical study results showing izicopan generated fewer potentially harmful reactive metabolites in human liver microsomes than marketed rival avacopan.Findings were presented with this announcement, positioning izicopan as a next-generation oral C5aR1 inhibitor with potential safety differentiation within the class.Data were based on a head-to-head laboratory assay designed to flag early bioactivation-related safety risk, with izicopan showing a more favorable profile than avacopan.InflaRx framed the results as supportive of izicopan’s differentiated profile, while noting in vitro outcomes do not directly predict clinical performance.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL1Q35gq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999014021.USD","IE00BN0W2W23.USD","BK4112","LU2095319765.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","SG9999014013.SGD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4139","BK4588","LU2210149790.SGD","BK4585","IFRX","NDAQ","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632108126","title":"InflaRx NV  expected to post a loss of 14 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2632108126","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632108126?lang=en_us&edition=fundamental","pubTime":"2026-05-01 21:48","pubTimestamp":1777643286,"startTime":"0","endTime":"0","summary":"InflaRx NV  expected to post a loss of14cents a share - Earnings Preview InflaRx NV IFRX.OQ, IFRX.O is expected to  show a rise in quarterly revenue when it reports  results on May 7 for the period en","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nL8N41E14P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IFRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632113196","title":"InflaRx to report first-quarter results before market open, no conference call planned","url":"https://stock-news.laohu8.com/highlight/detail?id=2632113196","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632113196?lang=en_us&edition=fundamental","pubTime":"2026-05-01 19:30","pubTimestamp":1777635044,"startTime":"0","endTime":"0","summary":"InflaRx will publish first-quarter 2026 financial and operating results on May 7, 2026, before market open.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL66M7KP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014039.USD","BK4139","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU2210149790.SGD","LU2095319765.USD","LU2210150020.SGD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","SG9999014013.SGD","BK4585","SG9999014021.USD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IFRX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630067993","title":"InflaRx regains Nasdaq compliance after shares hold above $1 minimum bid price","url":"https://stock-news.laohu8.com/highlight/detail?id=2630067993","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630067993?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:39","pubTimestamp":1777376359,"startTime":"0","endTime":"0","summary":"InflaRx regained compliance with Nasdaq minimum bid price rule 5450, removing risk of a potential delisting process tied to its share price.Nasdaq notified InflaRx on April 27 that the stock closed at $1 or higher for 10 consecutive business days from April 13 to April 24.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL759J95:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","LU2210149790.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4112","LU2095319765.USD","BK4139","BK4585","NDAQ","LU2210150020.SGD","SG9999014021.USD","LU0314104364.USD","SG9999014005.SGD","IE00B64PRP62.GBP","BK4588","IFRX","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","SG9999014039.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629803754","title":"InflaRx Price Target Maintained With a $14.00/Share by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2629803754","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629803754?lang=en_us&edition=fundamental","pubTime":"2026-04-21 21:48","pubTimestamp":1776779280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IFRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 21, 2026 09:48 ET (13:48 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IFRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628210914","title":"April 2026 Penny Stocks To Watch For Potential Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2628210914","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628210914?lang=en_us&edition=fundamental","pubTime":"2026-04-17 01:05","pubTimestamp":1776359119,"startTime":"0","endTime":"0","summary":"The United States market has shown robust performance, rising 3.4% over the last week and 35% over the past year, with earnings projected to grow by 16% annually. In such a thriving market, identifying stocks with strong potential for growth often involves looking beyond well-known names to those that might not be on every investor's radar. Penny stocks, though an older term, remain relevant as they often represent smaller or newer companies that could offer surprising value and stability...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ifrx/inflarx/news/april-2026-penny-stocks-to-watch-for-potential-growth","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ifrx/inflarx/news/april-2026-penny-stocks-to-watch-for-potential-growth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4183","IFRX","LU1046422090.SGD","LFVN","TOUR","NAGE","BK4579","BK4007","BK4583","BK4023","BK4121","BK4134","LX","BK4142","DAVA","BK4166","LU0648005311.SGD","VFF","BK4531","BK4097","BK7511","MAPS","LU1235295612.USD","TLS","SIGA","LU0049112450.USD","BK4139","LU0084288595.USD","BK4189","DAVA.AU","BK7042","III","TLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626157055","title":"Analysts Offer Insights on Healthcare Companies: Pro Medicus Limited (OtherPMCUF) and InflaRx (IFRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2626157055","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626157055?lang=en_us&edition=fundamental","pubTime":"2026-04-10 10:00","pubTimestamp":1775786423,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on Pro Medicus Limited (PMCUF) and InflaRx (IFRX) with neutral ratings, indicating that the experts are ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pro-medicus-limited-otherpmcuf-and-inflarx-ifrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pro-medicus-limited-otherpmcuf-and-inflarx-ifrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","XBI","BK4581","BK4139","BK4137","PMCUF","HCSG","BK4585","BK4588","IFRX","LU0128526141.USD","LU0029874061.USD","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626223181","title":"InflaRx announces new izicopan in vitro findings","url":"https://stock-news.laohu8.com/highlight/detail?id=2626223181","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626223181?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:54","pubTimestamp":1775735684,"startTime":"0","endTime":"0","summary":"InflaRx (IFRX) announced new in vitro findings demonstrating that izicopan does not exhibit time-dependent inhibition of CYP3A4, an important indic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inflarx-announces-new-izicopan-in-vitro-findings-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inflarx-announces-new-izicopan-in-vitro-findings-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IFRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624682673","title":"InflaRx announces annual shareholder meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2624682673","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624682673?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:21","pubTimestamp":1775161306,"startTime":"0","endTime":"0","summary":"InflaRx set annual shareholder meeting for April 23, 2026 in Amsterdam.Shareholders will vote on adoption of statutory annual accounts for fiscal 2025.Ballots also cover appointment of KPMG Accountants for audit of 2026 statutory annual accounts.Director votes include reappointments of executive directors Niels Riedemann, Renfeng Guo, non-executive directors Nicolas Fulpius, Richard Brudnick, Hege Hellstrom.Other proposals include extending board authorizations to issue shares, exclude pre-emption rights, repurchase shares, amend articles to raise authorized share capital to EUR 43 million, approve new long-term incentive plan from 2027 with 6.5% annual share pool.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inflarx NV published the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL5BLVRB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IFRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624761515","title":"Guggenheim Reaffirms Their Buy Rating on InflaRx (IFRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624761515","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624761515?lang=en_us&edition=fundamental","pubTime":"2026-04-01 20:35","pubTimestamp":1775046927,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Yatin Suneja from Guggenheim maintained a Buy rating on InflaRx, with a price target of $14.00. The company’s share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-reaffirms-their-buy-rating-on-inflarx-ifrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-reaffirms-their-buy-rating-on-inflarx-ifrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IFRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623317712","title":"InflaRx presents vilobelimab data","url":"https://stock-news.laohu8.com/highlight/detail?id=2623317712","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623317712?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:10","pubTimestamp":1774872623,"startTime":"0","endTime":"0","summary":"InflaRx (IFRX) announced that data from the Phase 3 study of vilobelimab in pyoderma gangrenosum were featured in an oral presentation during the l...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inflarx-presents-vilobelimab-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inflarx-presents-vilobelimab-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IFRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623144563","title":"InflaRx vilobelimab Phase 3 pyoderma gangrenosum trial ends early for futility","url":"https://stock-news.laohu8.com/highlight/detail?id=2623144563","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623144563?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:32","pubTimestamp":1774870346,"startTime":"0","endTime":"0","summary":"InflaRx highlighted Phase 3 vilobelimab data in pyoderma gangrenosum in a late-breaking oral presentation at 2026 American Academy of Dermatology Annual Meeting in Denver, held March 27-31.Trial enrolled 54 patients before being stopped early for futility based on Independent Data Monitoring Committee recommendation.Primary endpoint of complete target ulcer closure reached 20.8% on vilobelimab versus 16.7% on placebo.Complete disease remission was 20.8% with vilobelimab versus 5.1% with placebo.InflaRx expects any future development work in pyoderma gangrenosum would likely be pursued with a partner.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL6SdK2q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BN0W2V16.EUR","BK4139","SG9999014013.SGD","LU2095319765.USD","BK4585","SG9999014021.USD","LU0314104364.USD","BK4112","SG9999014005.SGD","LU2210150020.SGD","SG9999014039.USD","IE00BN0W2W23.USD","NDAQ","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","BK4588","IE00B64PRP62.GBP","IFRX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":61,"code":"91000000","status":"200"}]}}